Brucellosis Vaccine Market Analysis

Brucellosis Vaccine Market Analysis

To get key market trends

  Download Free Sample

Based on type, the market is segmented into RB51 vaccines, S19 vaccines, B19 vaccines, and other types. The RB51 vaccines segment dominated the market with 43.7% of market share in 2023.

• RB51 vaccine has demonstrated high efficacy in protecting against brucella abortus infection in cattle. Studies have shown that RB51 vaccination significantly reduces the risk of abortion and transmission of brucella abortus to other animals, making it a preferred choice among livestock producers and veterinarians.

   

• In addition to this, RB51 vaccine provides long-lasting immunity and is considered safer than the older S19 vaccine, leading to high adoption of this vaccine, thereby fostering the growth of this segment.

   

Based on vaccine, the brucellosis vaccine market is classified into DNA vaccines, subunit vaccines, vector vaccines, and recombinant vaccines. The DNA vaccines segment held highest market share and is anticipated to grow at CAGR of 4.8% over the forecast period.

• The DNA vaccines segment has emerged as the dominant segment in the market, largely due to its innovative technology and exceptional performance.

   

• Owing to several advantages it offers including high immunogenicity, safety, and potential for cross-protection against diverse brucella species or strains, propels the growth of this segment.

   

• Moreover, DNA vaccines boast excellent stability and long shelf-life, making them convenient for storage, transportation, and administration in various environmental conditions. Thereby, significantly driving the growth of this segment.

Based on animal type, the brucellosis vaccine market is divided into cattle, sheep, goat, and other animal types. The cattle segment accounted for significant market share and is anticipated to reach USD 216.7 million by 2032.

• The dominance of the cattle segment in the market can be attributed to the economic importance of cattle in global food production, their high susceptibility to brucella abortus infections, the zoonotic nature of brucellosis, and regulatory mandates requiring vaccination.

   

• With cattle serving as a reservoir for brucella abortus and the potential risk of transmission to humans, preventing brucellosis in cattle is imperative, hence contributing to the growth of this segment.

   

Based on end-user, the brucellosis vaccine market is categorized into veterinary clinics & hospitals, animal care centers, and other end-users. The veterinary clinics & hospitals segment was valued at USD 146.4 million in 2023.

• The veterinary clinics & hospitals segment dominated the market due to its pivotal role as a centralized hub for vaccine distribution, administration, and expertise.

   

• These facilities serve as trusted sources of veterinary advice and guidance, offering specialized knowledge on disease prevention, including brucellosis vaccination protocols.

   

• Moreover, veterinary clinics and hospitals provide convenient access to brucellosis vaccination services, particularly in rural and remote areas where access to veterinary care may be limited, through vaccination clinics, mobile veterinary services, and on-farm visits.

North America brucellosis vaccine market was valued at USD 99.4 million in 2023 and is predicted to reach USD 150.7 million by the end of the forecast timeframe.

• North America boasts a significant livestock population, particularly cattle, which is highly susceptible to brucella abortus infection.

   

• With large cattle herds in countries like the U.S. and Canada, the risk of brucellosis transmission is heightened, necessitating widespread vaccination to prevent disease outbreaks and economic losses in the livestock industry.

   

• The region also benefits from advanced veterinary infrastructure, including well-established veterinary clinics, hospitals, and diagnostic laboratories equipped to handle brucellosis vaccination programs.

   

U.S. brucellosis vaccine market is anticipated to witness growth at 4.7% CAGR over the forecast years.

• The U.S. has stringent regulatory standards for animal health and food safety enforced by agencies such as the United States Department of Agriculture (USDA) and the Animal and Plant Health Inspection Service (APHIS).

   

• Regulatory mandates and vaccination requirements compel livestock producers to prioritize brucellosis vaccination to maintain market access, ensure compliance with regulatory standards, and meet export requirements.

   

• Furthermore, the U.S. leads in technological advancements in vaccine development, research, and innovation. Ongoing investments in research and development drive the development of novel vaccine formulations, delivery systems, and vaccination strategies, enhancing the efficacy and safety of brucellosis vaccines in the US market. Such aforementioned factors boost the growth of this market.

   

Germany held a significant position in global brucellosis vaccine market.

• According to National Institutes of Health, the annual incidence of brucellosis in Germany was 0.38/1,000,000 population, of which 75% are travel associated. With the increasing incidence of brucellosis Germany prioritizes brucellosis prevention as part of its public health initiatives, aiming to protect livestock populations and mitigate the risk of zoonotic transmission to humans.

   

• In addition, factors such as advanced veterinary infrastructure, strict regulatory standards, high livestock density, and technological advancements influence the growth of market in Germany.

   

India market is predicted to witness growth at considerable growth rate during the forecast period.

• According to 20^th Livestock Census, total livestock population in India were 535.78 million in 2019. Of which total number of cattle in the country were 192.49 million in 2019.

   

• This large livestock population, particularly the significant number of cattle, in India acts as a key driver in the market, highlighting the importance of vaccination efforts to safeguard animal health, ensure food security, and mitigate economic losses in the agricultural sector.